AbCellera Biologics Inc.
AbCellera Biologics Inc.
ABCL
Valuace
70
Růst
0
Zdraví
60
Cena
$ 3.89
Dnes
--0.06 (-1.44%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
1.2B
Obrat
0B
Zisk
0B
Aktiva
1B
Dluh
0B
ROE
-18%
ROA
-13%
PE
-7
PS
14
Cena 1R
2-7
⌀ Cena
3.82
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
26-02-2026
Poslední dividenda

Profil

Společnost AbCellera Biologics Inc. vyvíjí platformu pro zjišťování protilátek. Jeho kompletní platforma pro vyhledávání protilátek založená na umělé inteligenci prohledává a analyzuje databázi přirozených imunitních systémů, aby nalezla protilátky, které by mohly být vyvinuty jako léky. K 31. prosinci 2021 měla společnost 156 programů pro objevování, které byly buď dokončeny, probíhají nebo jsou předmětem smlouvy s 36 partnery. Společnost AbCellera Biologics Inc. spolupracuje na výzkumu a uzavírá licenční smlouvu se společností Eli Lilly and Company. Společnost byla založena v roce 2012 a sídlí ve Vancouveru v Kanadě.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
596
Založení
2020-12-11
Adresa
2215 Yukon Street
CEO
Carl L.G. Hansen

Podobné společnosti

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 20252024202320222021202020192018
Total Revenues75.175.128.838.0485.4375.2233.211.68.8
Cost of Revenues0.00.00.00.066.445.527.10.00.0
Gross Profit75.175.128.838.0419.0329.7206.011.68.8
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues44.99.017.14.25.16.57.310.09.26.6
Cost of Revenues0.00.00.00.00.038.30.00.09.17.4
Gross Profit44.99.017.14.25.1-31.87.310.00.1-0.8
Operating Income TTM 20252024202320222021202020192018
R&D Expenses0.00.00.0175.7107.962.129.410.15.8
Selling General & Admin Expenses0.00.00.075.266.848.815.84.02.9
Depreciation & Amortization22.222.297.030.959.738.113.93.80.9
Total Operating Expenses292.2292.2343.6275.2191.9107.841.714.08.0
Operating Income-217.1-217.1-314.8-237.2216.5204.4156.0-4.1-0.8
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.048.637.9
Selling General & Admin Expenses0.00.00.00.00.00.00.00.019.117.8
Depreciation & Amortization1.37.27.16.613.938.338.06.89.17.4
Total Operating Expenses73.485.266.766.977.861.9100.864.871.958.7
Operating Income-28.6-76.3-49.6-62.7-72.8-93.7-93.5-54.9-66.1-54.9
Net Income TTM 20252024202320222021202020192018
Interest Income28.328.338.542.216.13.30.30.20.0
Interest Expense0.00.00.00.04.05.26.50.20.2
Other Expense39.539.5114.463.222.614.71.81.9-0.4
IBT-177.6-177.6-200.4-174.0239.1219.1157.8-2.20.3
Income Tax Expense-31.2-31.2-37.5-27.680.665.738.90.21.3
Net Income-146.4-146.4-162.9-146.4158.5153.5118.9-2.40.3
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income5.96.87.68.18.79.69.810.411.010.7
Interest Expense0.00.00.00.00.00.00.00.016.70.0
Other Expense9.17.513.29.725.931.045.312.117.515.6
IBT-19.5-68.8-36.3-53.0-46.8-62.6-48.2-42.7-48.6-39.3
Income Tax Expense-10.6-11.6-1.6-7.4-12.6-11.5-11.3-2.1-1.5-10.7
Net Income-8.9-57.1-34.7-45.6-34.2-51.1-36.9-40.6-47.2-28.6
Per Share Data TTM 20252024202320222021202020192018
EPS$0.00$0.00$0.00$-0.51$0.56$0.56$0.53$-0.01$0.00
EPS Diluted$0.00$0.00$0.00$-0.51$0.50$0.48$0.45$-0.01$0.00
Shares Outstanding298.7298.7294.3289.2285.1275.8159.2215.4215.4
Diluted Shares Outstanding298.7298.7294.3289.2314.8318.3263.1237.7237.7
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.16$-0.10
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.16$-0.10
Shares Outstanding298.7298.9298.5297.7294.6294.9294.2292.7290.0289.5
Diluted Shares Outstanding298.7298.9298.5297.7294.6294.9294.2292.7290.0289.5
Current Assets TTM 2024202320222021202020192018
Cash And Equivalents173.3156.3133.3386.5476.1594.17.610.4
Short Term Investments522.0469.3627.3500.0246.80.00.00.0
Total Cash & ST Investments695.4625.6760.6886.5723.0594.17.610.4
Accounts Receivable67.792.164.438.6160.6213.24.44.2
Inventory0.00.01.11.51.71.40.00.0
Other Current Assets8.533.645.975.421.26.00.00.6
Total Current Assets771.6751.4872.01,025.5929.8813.312.615.2
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents108.292.4159.3156.3126.6148.3123.6133.3172.4179.7
Short Term Investments412.5460.6446.0469.3516.5522.0574.5627.3613.4615.9
Total Cash & ST Investments520.7553.1605.3625.6643.1670.4698.0760.6785.8795.7
Accounts Receivable41.5153.4126.692.163.267.768.864.475.586.2
Inventory0.00.00.00.00.00.00.71.11.21.4
Other Current Assets133.035.733.133.636.533.546.445.957.047.4
Total Current Assets695.1742.1765.0751.4742.9771.6813.9872.0919.5930.7
Long-Term Assets TTM 2024202320222021202020192018
Net Property, Plant & Equipment318.9340.4287.7217.3111.617.98.56.3
Goodwill47.847.847.847.847.831.50.00.0
Intangible Assets85.742.1120.4131.5148.4115.20.00.0
Long-Term Investments130.882.365.972.550.319.20.00.0
Other Long-Term Assets57.896.594.246.323.28.42.40.0
Total Long-Term Assets640.9609.2616.1515.4388.8192.210.86.3
Total Assets1,412.51,360.61,488.11,540.91,318.61,005.523.521.5
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment427.4424.0347.1340.4331.3318.9306.1287.7277.2259.6
Goodwill47.847.847.847.847.847.847.847.847.847.8
Intangible Assets39.340.341.242.152.685.7118.7120.4124.1126.7
Long-Term Investments93.390.481.682.384.1130.8122.165.962.958.8
Other Long-Term Assets53.157.561.696.5134.257.854.494.280.7113.4
Total Long-Term Assets660.9659.9579.2609.2649.9640.9649.1616.1592.7606.4
Total Assets1,356.01,402.11,344.21,360.61,392.81,412.51,463.11,488.11,512.21,537.2
Current Liabilities TTM 2024202320222021202020192018
Accounts Payable26.634.425.533.232.020.01.61.5
Short-Term Debt5.64.66.25.63.70.22.92.5
Other Current Liabilities31.816.568.458.077.576.70.10.1
Current Liabilities70.476.6119.0118.3120.7103.57.96.4
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable53.132.032.834.434.826.626.925.517.421.0
Short-Term Debt0.04.94.64.65.15.65.56.25.66.0
Other Current Liabilities0.05.012.016.526.231.861.968.469.768.3
Current Liabilities68.867.075.476.679.670.4104.9119.0110.2118.9
Long-Term Liabilities TTM 2024202320222021202020192018
Long-Term Debt66.560.771.276.736.45.94.00.9
Capital Leases66.565.477.476.736.43.73.10.0
Def. Tax Liability21.710.130.633.237.426.20.00.0
Total Liabilities177.3304.5335.8307.6292.8175.013.29.9
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt137.1137.263.260.766.366.568.171.275.278.1
Capital Leases0.0142.167.865.471.466.568.177.480.884.0
Def. Tax Liability9.710.110.110.112.821.730.330.633.233.2
Total Liabilities392.0395.0321.2304.5314.7301.5333.2335.8329.4342.3
Total Common Equity TTM 2024202320222021202020192018
Common Stock770.0777.2753.2734.4722.4710.45.15.1
Retained Earnings202.2116.9279.8426.2267.7114.2-4.7-2.5
Comprehensive Income-2.1-4.4-1.7-1.40.30.00.0-1.6
Total Common Equity1,111.01,056.11,152.31,233.31,025.7830.510.311.6
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock794.5791.7790.1777.2772.8770.0764.6753.2747.9744.8
Retained Earnings-20.536.671.3116.9151.1202.2239.2279.8326.9355.5
Comprehensive Income-2.7-2.7-7.0-4.4-1.2-2.1-1.8-1.7-1.5-1.9
Total Common Equity964.01,007.11,023.01,056.11,078.11,111.01,129.91,152.31,182.81,194.8
Other TTM 2024202320222021202020192018
Total Debt72.165.477.482.336.46.16.93.4
Book Value1,235.21,056.11,152.31,233.31,025.7830.510.311.6
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value964.01,007.11,023.01,056.11,078.11,111.01,129.91,152.31,182.81,194.8
Cash Flow From Operating Activities TTM 20252024202320222021202020192018
Net Income-153.3-146.4-162.9-146.4158.5153.5118.9-2.20.3
Depreciation & Amortization61.322.297.030.933.117.35.31.80.9
Stock-Based Compensation67.555.867.664.249.530.68.40.90.6
Change Working Capital-26.2-70.7-25.813.229.841.7-116.72.01.9
Change In Accounts Receivable-55.9-55.6-75.1-45.9-22.7-37.4-5.5-1.8-0.5
Change In Accounts Payable-12.43.510.6-15.11.11.46.60.00.2
Change In Inventories7.20.00.018.30.040.9-134.30.0-0.9
Other Non-cash Items117.07.8-84.4-7.78.53.64.70.2-0.2
Cash from Operations-90.90.00.0-43.9277.4244.622.72.73.6
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-8.9-57.1-34.7-45.6-34.2-51.1-36.9-40.6-47.2-28.6
Depreciation & Amortization9.07.27.16.6-18.138.338.06.89.17.4
Stock-Based Compensation12.913.914.214.815.20.00.017.416.415.9
Change Working Capital-46.0-18.1-16.810.5-15.9-5.8-7.8-27.01.47.2
Change In Accounts Receivable-39.54.2-19.0-1.1-20.9-19.9-15.6-18.6-10.4-11.2
Change In Accounts Payable5.85.1-3.9-3.40.04.14.7-4.9-13.31.0
Change In Inventories0.00.00.00.00.00.00.00.0-7.815.0
Other Non-cash Items-1.71.5-2.12.245.0-10.4-22.81.7-1.4-1.9
Cash from Operations0.00.00.00.00.00.00.00.0-19.6-0.1
Cash Flow From Investing Activities TTM 20252024202320222021202020192018
Capital Expenditure-79.3-42.8-78.4-77.5-72.7-58.5-14.7-4.0-5.3
Acquisitions-17.80.0-19.6-13.7-25.7-41.8-106.90.00.0
Investments-934.2-436.0-765.1-1,066.2-781.4-292.20.00.00.0
Sales of Investment1,027.60.0948.8910.9510.627.60.00.00.0
Other Investing Activities37.20.00.025.316.432.61.8-1.80.0
Cash from Investing44.30.00.0-221.1-352.6-332.2-119.8-5.8-5.3
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-9.8-8.9-13.4-10.6-15.6-18.6-19.8-24.1-14.4-20.9
Acquisitions-2.6-2.5-2.60.00.00.00.0-5.9-3.5-3.5
Investments-119.5-36.2-134.7-165.00.0-194.0-174.1-253.8-284.7-215.8
Sales of Investment113.483.1113.40.00.0207.1232.9306.5268.0220.1
Other Investing Activities0.00.00.00.00.00.00.00.010.37.3
Cash from Investing0.00.00.00.00.00.00.00.0-24.3-12.8
Cash Flow From Financing Activities TTM 20252024202320222021202020192018
Debt Repaid-15.40.00.011.6-0.3-1.8-19.9-0.4-0.9
Debt Issued3.465.4-12.06.746.232.119.23.84.3
Issuance of Common Stock1.30.00.00.00.00.0522.80.02.6
Repurchase of Common Stock0.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.0
Other Financing Activities-0.90.00.0-1.2-1.3-2.1180.80.610.5
Cash from Financing15.80.00.010.4-1.6-3.9683.70.212.2
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.04.07.0
Debt Issued137.1-5.074.22.5-6.0-0.7-1.6-3.80.63.7
Issuance of Common Stock0.00.00.00.00.00.00.00.00.00.0
Repurchase of Common Stock0.00.00.00.0-1.60.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.0-0.2-0.4
Cash from Financing0.00.00.00.00.00.00.00.03.86.6
Cash position TTM 20252024202320222021202020192018
Net Change in Cash-33.0-28.423.0-254.0-86.5-93.0586.6-2.910.4
Closing Cash Balance173.3155.2183.6160.6414.7501.1594.17.610.4
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash44.8-9.3-66.82.929.7-21.724.7-9.7-39.1-7.3
Closing Cash Balance155.2110.4119.7186.6183.6151.6173.3150.9160.6199.7
Free Cash Flow TTM 20252024202320222021202020192018
Free Cash Flow-170.1-174.1-187.0-121.4204.7186.18.0-1.3-1.7
Real Free Cash Flow-237.6-229.9-254.5-185.6155.2155.5-0.4-2.2-2.4
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow-44.6-61.5-45.8-22.2-23.6-47.6-49.3-65.8-34.0-21.0
Real Free Cash Flow-57.5-75.4-60.0-37.0-38.9-47.6-49.3-83.3-50.5-36.9
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-6.9697.9-1.4
P/S13.5279.4
P/B1.15.15.2
P/FCF-4.4-1592-1.5
Market cap$1.2$1.3
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets10.1 %5.5 %0 %
Debt to Income-93.6 %41.6 %0 %
Debt to Free cash flow-59.6 %62.7 %0 %
Interest expense percentage0 %0.4 %44.7 %
Current ratio10.1 8.4 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-15.2 %1 %0 %
ROA-10.8 %0.7 %0 %
CapEx to Revenue137.5 %88.8 %0 %
RaD to Revenue0 %181.2 %0 %
ROEM125,213.3 461755.6

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin80 %24.2 %68.7 %
Operating margin-739.7 %-279.9 %35.5 %
Net margin-486 %-153.3 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding298.9 mil 287.4 mil
Employee count0.6 tis 0.5 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader